Preliminary Pilot Assessment of TSPAN32 Detectability in Peripheral Blood as a Potential Circulating Biomarker in Advanced-Stage Nasopharyngeal Carcinoma Patients Undergoing Chemoradiation.
Mulansari NA, Paramita RI, Wanandi SI, Sudoyo AW, Yudharto MA
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.